Jane Street Group, LLC Abcam PLC Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$21.54 - $24.41 $1.07 Million - $1.22 Million	-49,829 Reduced 70.98%	20,373 $461,000
Q2 2023 Aug 14, 2023	SELL	$12.62 - $24.47 $2.78 Million - $5.38 Million	-219,894 Reduced 75.8%	70,202 $1.72 Million
Q1 2023 May 15, 2023	SELL	$12.98 - $17.1 $4.76 Million - $6.27 Million	-366,639 Reduced 55.83%	290,096 $3.9 Million
Q4 2022 Feb 14, 2023	BUY	$13.92 - $17.0 $8.94 Million - $10.9 Million	642,295 Added 4448.03%	656,735 $10.2 Million
Q3 2022 Nov 14, 2022	BUY	$13.36 - $16.75 $192,918 - $241,870	14,440 New	14,440 $216,000
Q3 2021 Nov 16, 2021	SELL	$17.38 - $21.54 $192,344 - $238,383	-11,067 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.47 - $22.11 $204,407 - $244,691	11,067 New	11,067 $211,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.